{"id":"doi:10.1158/1078-0432.ccr-15-1507","kind":"review","title":"The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition","authors":["Priti S. Hegde","Vaios Karanikas","Stefan Evers"],"author_count":3,"year":2016,"published":"2016-04-14","venue":"Clinical Cancer Research","cited_by":1000,"doi":"10.1158/1078-0432.ccr-15-1507","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1158/1078-0432.ccr-15-1507","archive_url":"https://space-kitty.com/papers/doi:10.1158/1078-0432.ccr-15-1507","updated":null,"pmid":"27084740","pmcid":null,"openalex_id":"W2338576144","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}